Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?

@article{Zheng2001LysozymeER,
  title={Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?},
  author={Feng Zheng and Weijing Cai and T Mitsuhashi and Helen Vlassara},
  journal={Molecular medicine},
  year={2001},
  volume={7 11},
  pages={
          737-47
        }
}
BACKGROUND Lysozyme (LZ), a host-defense protein, contains an 18 amino-acid domain with high affinity binding for sugar-derived proteins or lipids, called advanced glycation endproducts (AGE), that are implicated in diabetes- and age-dependent complications (DC). MATERIALS AND METHODS A) The effects of LZ on AGE- removal were tested in vivo. LZ was injected (200 ug/day, i.p., X2 weeks) in non-obese diabetic (NOD), db/db (+/+) mice, and non-diabetic, AGE-infused Sprague-Dawley rats. B) LZ: AGE… CONTINUE READING
22 Citations
48 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Differential expression and function of advanced glycation endproduct (AGE)receptor genes in NOD mouse kidneys; possible role in diabetic and non-diabetic renal disease

  • C-J He, F Zheng, J Sabol
  • Kidney Int
  • 2000
10 Excerpts

Retriction of AGE content of food, without lowering protein intake prevents diabetic nephropathy (DN) in mice

  • F Zheng, C He, J Li, H. Vlassara
  • Diabetes Supplement I
  • 2000
1 Excerpt

Low AGE-diet ameliorates nephropathy in non-obese diabetic (NOD) mice

  • CJ He, J Li, MHM Steffes
  • Diabetes Supplement
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…